Dasatinib overcomes imatinib and nilotinib failure in Philadelphia chromosome positive chronic myeloid leukemia with different mechanisms of resistance

Leuk Lymphoma. 2009 May;50(5):848-50. doi: 10.1080/10428190902829425.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Benzamides
  • Dasatinib
  • Drug Resistance, Neoplasm / drug effects*
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Male
  • Piperazines / pharmacology
  • Piperazines / therapeutic use
  • Pyrimidines / pharmacology*
  • Pyrimidines / therapeutic use
  • Thiazoles / pharmacology*
  • Thiazoles / therapeutic use

Substances

  • Benzamides
  • Piperazines
  • Pyrimidines
  • Thiazoles
  • Imatinib Mesylate
  • nilotinib
  • Dasatinib